Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Osborne

Vascular & Interventional Radiology Union City, TN Medical Doctor

NPI 1659698942 CMS profile 1294345

1720 E Reelfoot Ave Ste 200, Union City, TN 38261

Open in the dashboard

General payments

$10,943

87 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scott Osborne of Union City, TN is reported in the CMS Open Payments database as having received $10,943 across 87 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,849 30
2024 General $590 10
2023 General $2,512 24
2022 General $318 5
2021 General $1,435 7
2020 General $374 4
2019 General $865 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Osborne
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Scott Osborne were reported at $4,849. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Scott Osborne Vascular & Interventional Radiology median Middle half National median
2019 $865 $422 $125–$1,555 $163
2020 $374 $200 $68–$652 $114
2021 $1,435 $280 $99–$866 $132
2022 $318 $433 $137–$1,497 $149
2023 $2,512 $506 $152–$2,019 $160
2024 $590 $556 $175–$1,930 $164
2025 $4,849 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $5,582 34 payments
  2. Inari Medical, Inc. $2,508 14 payments
  3. Boston Scientific Corporation $1,259 15 payments
  4. Penumbra, Inc. $282 2 payments
  5. Stryker Corporation $261 3 payments
  6. Terumo Medical Corporation $186 4 payments
  7. Sirtex Medical Inc $174 2 payments
  8. Surefire Medical, Inc. $152 1 payment
  9. Biocompatibles, Inc. $143 1 payment
  10. Shockwave Medical, Inc $142 1 payment
  11. Other $253 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,755 70 payments
  2. Travel and Lodging $5,187 17 payments
Products named General payments · program years 2019–2025
  1. AURYON LASER SYSTEM 100-120 VAC $2,572 24 payments
  2. FLOWTRIEVER CATHETER, S $2,162 13 payments
  3. ANGIOVAC $1,792 3 payments
  4. CT THROMBECTOMY SYSTEM KIT $1,680 9 payments
  5. ALPHAVAC $1,219 7 payments
  6. FlowTriever $761 5 payments
  7. ClotTriever $761 5 payments
  8. JETSTREAM SC $750 2 payments
  9. Indigo $282 2 payments
  10. SIR-Spheres Microspheres $174 2 payments
  11. Other $1,430 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

123

Median for Diagnostic Radiology: 24

Drug cost

$603

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciprofloxacin Hcl Generic 49 $334
Solifenacin Succinate Generic 37 $210
Ibuprofen Generic 37 $59

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 186 billing codes

Paid by Medicare

$450,015

Of which drugs: $1,059

Medicare patients

827

Average age 74

Services billed

11,212

435 women, 392 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 47%
Diabetes 44%
Chronic kidney disease 42%
Heart failure 36%
Atrial fibrillation 33%
Depression 30%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 59 9,100 $966
Injection, fentanyl citrate, 0.1 mg J3010 Office 54 57 $41
Injection, midazolam hydrochloride, per 1 mg J2250 Office 53 114 $12

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

87 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record